Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Nocion Therapeutics is raising $24,999,994.00 in new funding. Sources indicate as part of senior management President and Chief Operating Officer, Rick Batycky played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Nocion Therapeutics

NOCION is a biopharmaceutical company that is addressing vexing medical problems head on. We are developing nocions a new kind of therapy that selectively affects actively firing nociceptors to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation. Our focused platform may be applied to a broad range of applications. We’re actively finalizing leads to create a suite of product candidates intended to treat a wide variety of conditions.

To learn more about Nocion Therapeutics, visit http://www.nociontx.com/

Contact:
Rick Batycky, President and Chief Operating Officer
781-819-2877
https://www.linkedin.com/in/rick-batycky-221a7011/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved